ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research

Contributed by: PR Newswire

Tags

ACROBiosystems-AG

More Like This

PR Newswire associated0

ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers

ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)

Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

PR Newswire associated0

GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research

Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)

Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024